Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Hb Benedict

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis and Related Disorders|October 8, 2020
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 yearsLucie Friedova, Jiri Motyl, Barbora Srpova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 4, 2018
Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis ConsortiumCaila B Vaughn, Katelyn S Kavak, Michael G Dwyer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2022
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 yearsBruce Ac Cree, Douglas L Arnold, Robert J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2020
Recovery of cognitive function after relapse in multiple sclerosisRalph Hb Benedict, Jeta Pol, Faizan Yasin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2022
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trialDouglas L Arnold, Daniela Piani-Meier, Amit Bar-Or, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 18, 2018
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in JapanMasaaki Niino, Toshiyuki Fukazawa, Jun-Ichi Kira, et al.
Multiple Sclerosis and Related Disorders|October 25, 2022
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemicDejan Jakimovski, Katelyn S Kavak, Erin E Longbrake, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2023
Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speedZachary L Weinstock, Michael Jaworski, Michael G Dwyer, et al.
Multiple Sclerosis and Related Disorders|April 28, 2024
Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosisDejan Jakimovski, Bianca Weinstock-Guttman, Alex Burnham, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis and Related Disorders|October 8, 2020
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 yearsLucie Friedova, Jiri Motyl, Barbora Srpova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 4, 2018
Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis ConsortiumCaila B Vaughn, Katelyn S Kavak, Michael G Dwyer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2022
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 yearsBruce Ac Cree, Douglas L Arnold, Robert J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2020
Recovery of cognitive function after relapse in multiple sclerosisRalph Hb Benedict, Jeta Pol, Faizan Yasin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2022
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trialDouglas L Arnold, Daniela Piani-Meier, Amit Bar-Or, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 18, 2018
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in JapanMasaaki Niino, Toshiyuki Fukazawa, Jun-Ichi Kira, et al.
Multiple Sclerosis and Related Disorders|October 25, 2022
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemicDejan Jakimovski, Katelyn S Kavak, Erin E Longbrake, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2023
Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speedZachary L Weinstock, Michael Jaworski, Michael G Dwyer, et al.
Multiple Sclerosis and Related Disorders|April 28, 2024
Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosisDejan Jakimovski, Bianca Weinstock-Guttman, Alex Burnham, et al.
Pageof 7